Extracted from this filing and checked against the source text.
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Claritev Corp completed an acquisition involving Benefits Science LLC for $160.0 million (closed 2023-05-08).
- Action
- acquisition
- Counterparty
- Benefits Science LLC
- Consideration
- $160.0 million
- Closing
- 2023-05-08
Exact text from the filing
On May 8, 2023, Buyer purchased all of the issued and outstanding equity interests of Benefits Science Technologies (the " Acquisition ") for aggregate consideration of $160.0 million paid at the closing of the Acquisition
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Claritev Corp entered into Unit Purchase Agreement with Benefits Science LLC valued at $160.0 million (effective 2023-05-08).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- Benefits Science LLC
- Value
- $160.0 million
- Effective
- 2023-05-08
Exact text from the filing
On May 8, 2023, Babylon Acquisition Corp., a Delaware corporation and recently formed, wholly owned, indirect subsidiary of MultiPlan (" Buyer "), Benefits Science LLC, a Texas limited liability company (" Benefits Science Technologies " or " BST "), the sellers listed on the signature pages thereto (" Sellers "), MultiPlan, solely for purposes of Section 2.2(a)(ii), MultiPlan, Inc., a New York corporation, solely for purposes of Section 2.2(f)(ii)(x), and WT Representative LLC, solely in its capacity as representative to the Sellers, entered into that certain Unit Purchase Agreement (the " Purchase Agreement ") pursuant to which, on May 8, 2023, Buyer purchased all of the issued and outstanding equity interests of Benefits Science Technologies (the " Acquisition ") for aggregate consideration of $160.0 million paid at the closing of the Acquisition in the form of (i) cash consideration in an aggregate amount of approximately $140.8 million, subject to customary adjustments for working
View on SEC.gov